ACTA NEUROPHARMACOLOGICA››2021,Vol. 11››Issue (2): 26-31.DOI:10.3969/j.issn.2095-1396.2021.02.006

Previous ArticlesNext Articles

Research Progress of Mitochondrial Permeability Transition Pore in Cerebral Ischemia-Reperfusion Injury

SUN TingXIE Jia-jiaZHANG Dan-shen

  1. College of Chemical and Pharmaceutical EngineeringHebei University of Science and TechnologyShijiazhuang050018China

  • Online:2021-04-26Published:2021-04-26
  • Contact:张丹参,女,博士生导师;研究方向:神经药理学;Tel:+86-0311-81668016,E-mail:zhangds2011@126.com
  • About author:孙婷,女,硕士研究生;研究方向:神经药理学;E-mail:sunting2020@126.com
  • Supported by:
    河北省重点研发计划项目生物医药专项( No.20372509D ),河北省自然科学基金( No.H2020208032 ),河北省高等学校科学技术研 究项目( No.ZD2020117 ),河北省中医药管理局中医药科研计划项目( No.2020268 ),中央财政公共卫生专项“中药资源普查项目” No.Z135080000022

Abstract:

Ischemic cerebrovascular disease is one of the main diseases threatening human health. Restoring blood and oxygen supply to brain tissue as soon as possible is an effective means to save patients’ lives and reduce disability rate. Howeverafter restoring blood and oxygen supply to brain tissuemore serious injury may occurnamely cerebral ischemiareperfusion injuryI/R. As an important organelle for energy productionmitochondria are very important for the survival of neurons. Among the many potential mechanisms of mitochondrial dysfunctionthe opening of mitochondrial permeability transition poremPTPhas attracted more and more attention in recent years. mPTP is a key node mediating brain dysfunction and cell death. This paper systematically summarizes the research status of mitochondrial permeability transition pore and cerebral ischemia-reperfusion injury in order to provide a new treatment idea for clinical treatment of cerebral ischemia-reperfusion injury.

Key words:

font-family:Times,"> mitochondrial permeability transition porefont-family:Helvetica,">,cerebral ischemia-reperfusion injuryfont-family:Helvetica,">,cyclophilin Dfont-family:Helvetica,">,research progress

CLC Number:

Baidu
map